Please login to the form below

Not currently logged in
Email:
Password:

tenofovir alafenamide

This page shows the latest tenofovir alafenamide news and features for those working in and with pharma, biotech and healthcare.

Gilead’s Biktarvy received EC approval for the treatment of HIV in paediatric populations

Gilead’s Biktarvy received EC approval for the treatment of HIV in paediatric populations

Gilead Sciences (Gilead) has announced that the European Commission (EC) has authorised a new low-dose tablet dosage form of Biktarvy (bictegravir/emtricitabine/tenofovir alafenamide) and an extension of its indication

Latest news

More from news
Approximately 4 fully matching, plus 44 partially matching documents found.

Latest Intelligence

More from intelligence
Approximately 0 fully matching, plus 1 partially matching documents found.

Subscribe to our email news alerts

PMHub

Add my company
Evoke Mind+Matter

We are Evoke Mind ‘PLUS’ Matter. The ‘plus’ is important to us because we are all about offering more for...

Latest intelligence

The evolving healthcare advertising landscape
Industry experts share their insights on the emerging trends in healthcare advertising...
Clinical trial considerations: Why supporting HCPs matters...
When HCPs have the necessary information, they can more easily communicate it to patients using simplified language and a confident, calm tone....
Six ways to provide successful e-learning programs to healthcare professionals
Practical tips to setting up high-impact e-learning programs...